The ecotropic viral integration site-1 (Evil) locus was initially identified as a common site of retroviral integration in myeloid tumors of the AKXD-23 recombinant inbred mouse strain. The full-length Evil transcript encodes a putative transcription factor, containing ten zinc finger motifs found within two domains of the protein. To determine the biological function of the Evil proto-oncogene, the full-length, but not an alternately spliced, transcript was disrupted using targeted mutagenesis in embryonic stem cells. Evil homozygous mutant embryos die at approximately 10.5 days post coitum. Mutants were distinguished at 10.5 days post coitum by widespread hypocellularity, hemorrhaging, and disruption in the development of paraxial mesenchyme. In addition, defects in the heart, somites, and cranial ganglia were detected and the peripheral nervous system failed to develop. These results correlated with whole-mount in situ hybridization analyses of embryos which showed expression of the Evil proto-oncogene in embryonic mesoderm and neural crest-derived cells associated with the peripheral nervous system. These data suggest that Evil has important roles in general cell proliferation, vascularization, and cell-specific developmental signaling, at midgestation.
Introduction
The properties of the Evil proto-oncogene predict an important role for this gene in mammalian development. Evil was initially identified as a common site of retroviral integration in myeloid tumors . Evil is not, however, normally expressed in hematopoietic lineages (Morishita et al., 1990b) . Generally, ectopic expression of Evil is associated with improved survival (Morishita et al., 1992; Kreider et al., 1993) or increased cell proliferation /~Iitani et al., 1995) , consistent with its role as an oncogene. In adult mice, Evil expression is detected in the renal tubules in the corticomedullary junction of the kidney and the cytoplasm of developing oocytes (Morishita et al., 1990b) . Fetal expression has been reported in the urinary system, limb buds, heart, nasal pits, bronchial epithelium, and other tissues (Perkins et al., 1991b) .
The Evil gene encodes a transcription factor. The 145 kDa glycosylated protein contains ten zinc finger motifs and an acidic region similar to known transcriptional activation domains (Morishita et al., 1988) . The Evil full-length mRNA is 5.7 kb in length. An alternatively processed 4.7 kb Evil mRNA has been characterized which results in a deletion of 324 amino acids including the sixth and seventh zinc fingers of the amino-terminal domain, and a putative nuclear localization signal (Bordereaux et al., 1990; Bartholomew and Clark, 1994) . A similar alternatively spliced transcript has been identified in humans (Morishita et al., 1990a) . The Evil gene product has been localized to the nucleus, and is a sequence-specific DNA-binding protein with different sequence specificities in the amino-and carboxy-terminal zinc finger clusters (Perkins et al., 1991a; Delwel et al., 1993; Funabiki et al., 1994) . Evil is conserved evolutionarily, with homologous genes identified in humans (Morishita et al., 1990a) and Xenopus (C.V.E. Wright and J.N. Ihle, unpublished data) . In addition, Egl-43, a gene containing six zinc fingers that are similar to zinc fingers 5-10 of the murine Evil gene, has been identified in Caenorhabditis elegans (Garriga et al., 1993) .
In vitro studies indicate that Evil can repress Gataldependent transactivation during erythropoiesis . In contrast, Evil increases activity of transcription factor AP-1, presumably through transactivating Cfos . The Cjun oncogene is also transactivated in rat fibroblast cell lines when an AML1/ Evil chimeric gene is ectopically expressed . In these studies, transformation and transactivation of Cjun were dependent on the presence of Evil sequences. The overexpression of Evil in the 32Dc13 myeloid cell line inhibits differentiation of these cells to granulocytes in response to G-CSF (Morishita et al., 1992) . Growth factor requirements and the initial proliferative response of these cells to growth factors were unaffected. Recently, this cell line has been shown to constitutively express Evil due to a retroviral integration (Khanna-Gupta et ai., 1996) . Together these results indicate a relatively high threshold level of Evil expression is needed to inhibit specific differentiation events. When ectopically expressed in erythroid cells, or in bone marrow hematopoietic progenitors, Evil can also prevent differentiation in response to erythropoietin .
The ability to inhibit differentiation may be an important factor in the neoplasia resulting from aberrant Evil expression. In the absence of detectable chromosomal changes, aberrant transcription of the highly conserved human EVIl locus can be detected in myeloid cells from approximately 30% of all myelodysplastic syndrome (MDS) patients (Russell et al., 1994) . The human EVIl gene is also activated by translocations or inversions in MDS or acute myelogenous leukemia (AML) patients (Fichelson et al., 1992; Jotterand Bellomo et al., 1992; Oval et al., 1992; Russell et al., 1993; Levy et al., 1994; Mitani et al., 1994; Nucifora et al., 1994) . Chimeric transcripts resulting from translocations and including EVIl coding sequence have been characterized and shown to indirectly activate the Cfos and Cjun gene promoters which affects the activity of the transcription factor AP-1 Nucifora et al., 1994; Tanaka et al., 1994 Tanaka et al., , 1995 . This indicates that Evil has the potential to operate in a transcriptional cascade or signal transduction pathway.
To better define the normal developmental functions of the Evil gene, a targeted mutation that specifically eliminated the full-length transcript was generated. Resulting heterozygous mice were indistinguishable from wild-type littermates, but homozygous mutant animals died in utero at approximately 10.5 days post coitum (d.p.c.) due to pleiotropic developmental defects.
Results

Targeted mutagenesis of the Evil gene
To begin to define its biological function, the Evil gene was subjected to a targeted insertional mutation that would specifically disrupt the full-length transcript at nucleotide 1304. This insertion did not produce a null-allele, as the alternatively spliced A324 transcript persists (see below). Fig. 1A shows the restriction map of an EcoRI genomic DNA fragment of the normal Evil allele containing exons 5 and 6. Also shown is the targeting vector pCB 1Ex6neol, derived from this fragment (Fig. 1B) . The double homologous recombination between replacement vector and the endogenous gene disrupted the sixth exon of Evil. This exon was specific to the full-length Evil mRNA and encoded two of the ten zinc fingers as well as the putative nuclear localization signal. A total of 1056 ES cell colonies were examined, of which eight were shown to be correctly targeted based on PCR and Southern blot analyses. Fig. 1D illustrates the presence of a targeted allele in six ES colonies. The greater intensity of the band corresponding to the non-targeted allele in some cases, such as C195 and C634, suggested the presence of mixed cell populations, with fewer than 100% of the cells targeted. Five individual ES cell clones were injected into C57BL/6J blastocysts and the injection of clone 634 resulted in germline transmission of the targeted allele. Heterozygous progeny were phenotypicaily normal and crosses of heterozygous animals produced no homozygous animals at birth, indicating a prenatal lethality. Subsequently, embryos were harvested at specific days of gestation to determine the time of death. All embryos in this report were unambiguously genotyped using PCR analysis of yolk sac DNA, as described in Section 4. No viable mutant embryos were detected by 11.5 d.p.c., but mutant embryos were present at normal Mendelian ratios at 10.5 d.p.c, based on genotyping of yolk sac DNA (see Table 1 ). Analysis of over 200 embryos at 9.5 d.p.c, failed to reveal any gross malformations in mutants. In the analysis of over 500 embryos at 10.5 d.p.c., mutant embryos were accurately identified by gross observation 100% of the time because they exhibited multiple specific phenotypic abnormalities described below. All grossly normal appearing embryos were proven to be either wild-type (+/+), or heterozygous (+/-) at the Evil locus, by PCR analysis. 
Homozygous Evil mutants die in utero with multiple malformations
A distinguishing feature of mutant embryos, first seen at 10.5 d.p.c., was the pale appearance of their yolk sacs ( Fig.  2A) . The amnion of 10.5 d.p.c, mutants was also engorged with fluid and attached at several sites to the yolk sac. Upon dissection, the placental connections and connections between the yolk sac and the embryo were grossly normal, although the placenta was visibly more pale than that of normal littermates. d.p.c.. The defects observed included extravasated hematopoietic cells (hemorrhaging), enlarged pericardial sac, a malformed forebraln, and a dramatically reduced cellularity in an area ventral to the neural tube from the cephalic flexure in the head and extending posteriorly to the approximate level of the hindlimb bud. This hypocellularity is more clearly visible in histological sections (see Fig. 3B ). Homozygous mutant embryos were slightly smaller than wildtype and had reduced numbers of somite pairs after the 32 somite stage (approximately 10.25 d.p.c). The cessation of heartbeat was used to define the time of embryonic death, and occurred shortly after 10.5 d.p.c., when normal litter- 
Histopathology of Evil mutant embryos: mesenchymal defects
Histopathological analyses revealed widespread hypocellularity in mutants at 10.5 d.p.c. A striking feature of mutant embryos was the reduction or ablation of mesenchymal cells within the head and, caudally, in the region ventral to the neural tube and dorsal to the developing heart and gut ( Fig.  3A-D) . The affected cells correspond to the non-segmented paraxial mesoderm-derived mesenchyme. This mesenchymal cell malformation was first observed in approximately 10.0 d.p.c, mutants near the notochord. By 10.5 d.p.c, the hypocellularity had progressed to the sides of the head and anteriorly toward the brain ventricles. In many areas this resulted in the exposure of the neural ectoderm to an internal cavity, and was accompanied by a variable amount of swelling. Neural crest-derived ectomesenchyme on the sides of the head remained more normal in appearance (Fig. 3D) . Dissection of mutant embryos revealed that the cavity was filled with a gelatinous reticulum, which may be the result of degradation of cells derived from the paraxial mesoderm.
Brain and neural tissue defects
By 10.5 d.p.c, the development of the brain was severely retarded. Gross observation of the head of mutant animals indicated that the growth of the telencephalic vesicles was consistently reduced when compared to normal littermates (Fig. 2B ). Histological examination of 10.5 d.p.c, mutants revealed that the inferior region of the diencephalon near the cephalic flexure was also malformed in most mutants (Fig.  3B ). Also in 10.5 d.p.c, mutants, the trigeminal ganglion complex and facio-acoustic ganglion complex appeared hypoplastic (Fig. 3E,F) .
Invariably, the neural ectoderm was thin in mutants, although neural tube closure appeared normal. In normal embryos, the marginal layer of the neural ectoderm borders the mesenchyme, and consists of fibrous extracellular matrix and nerve axon structures, but in mutants this layer was greatly reduced or absent (Fig. 4A,B) . Furthermore, while peripheral nerve bundles alongside or between somites were easily detected in histological sections of normal 10.5 d.p.c, embryos (Fig. 4A,C ), none were detected in the mutants at this age (Fig. 4B,D) . These results were confirmed using whole-mount immunohistochemistry and the neurofilament monoclonal antibody 2H3 (Developmental Studies Hybridoma Bank, Iowa City, IA). Rudimentary cranial ganglia without detectable spinal or cranial nerve development was observed in mutant embryos at both 9.5 and 10.5 d.p.c. (Fig. 5) . Cranial nerve development begins at approximately 9.25 d.p.c, and precedes spinal nerve development by approximately 18 h. In 9.5-9.75 d.p.c, mutants, defective formation of the superior regions of the glossopharengeal ganglion, the superior vagal ganglion, and the cranial accessory neuron are highly consistent mutant malformations ( 
Heart malformations
By 10.5 d.p.c., mutants hearts were clearly falling. Gross observations revealed that general circulation was poor, and that the beating heart produced only a refluxing of blood. The branchial arch vasculature appeared to be intact. The improper heart development is manifested in a looping defect giving the heart a more tube-like appearance. At this stage, the posterior part of the heart (atria) should be looping dorsally and anteriorly, changing the angle of the ventricle and outflow tract, relative to the embryo trunk. A constriction should also be present between the atria and ventricle. Mutants display a poorly developed constriction, and a definite looping defect that resembles retarded or arrested heart development.
Histological sections revealed that the degree of chamber development was delayed in mutant embryos. A consistent decrease in trabeculations was evident by 9.5 d.p.c. (Fig. 6 ). The retardation of ventricular development at this point could be the cause of eventual heart failure. By 10.5 d.p.c., the hearts are extensively delayed, appear to be failing, and the trabeculations contain large gaps (data not shown). The failed heart is indicated also by blood and fluid in the pericardial sac, and indication of pericardial effusion. Thus, embryonic death is probably due to compromised circulation.
Somite development
Peri-notochordal mesenchyme is primarily derived from Clearing in the head mesenchyme of the mutant is marked with an asterisk (*). Hemorrhaging in this mutant is seen by red discoloration behind the heart, and in the tnmk region ventral to the forelimb bud. The initial stage of pericardial sac swelling is evident. Abbreviation: fb, forelimb bud. sclerotomal cells migrating from the somites. Histologically, somites in Evil mutants were unremarkable at 9.5 d.p.c., but were distinctly hypocellular by 10.5 d.p.c. At this stage, the dermatome remained grossly normal in shape and cell morphology, but the myotome was markedly hypoplastic, and in many instances appeared to be absent (Fig. 7A,B) . The sclerotome, and the medial positioning of migrating sclerotomal cells, appeared grossly normal in mutants at 9.5 d.p.c, but was difficult to discriminate in later embryos due to increasing acellularity in this region.
Subtle developmental alterations in Evil mutant embryos
The limb buds, mesonephros, liver, and branchial arches of mutant embryos were also abnormal when compared to wild-type littermates. Forelimb buds in 9.5 d.p.c, mutants were similar to littermates suggesting that their initial formation was unaffected, but 10.5 d.p.c, mutant embryo limb buds were smaller. Hindlimb buds were rarely seen in mutants. Histological examination of mutant forelimb buds at 10.5 d.p.c, revealed a relatively normal ectodermal cell morphology, vascularization, and the presence of an apical ectodermal ridge (AER) (Fig. 7C,D) .
Evil is expressed in the developing kidney at 9.5 d.p.c. (Perkins et al., 1991b) . Therefore, we examined mutants for changes in the mesonephros and the genital ridges which arise from the intermediate and lateral plate mesoderm. The mesonephric duct and tubules were small and hypocellular but clearly visible in sections of all mutant embryos at 10.5 d.p.c. (Fig. 7E,F) .
Histological sections of the liver primordium in 10.5 d.p.c, mutant animals was highly pyknotic and hypoplastic when compared to normal littermates (data not shown). The branchial arches were disproportionately smaller, slightly pyknotic, but with relatively normal cell density.
Whole-mount in situ hybridization to Evil mRNA
The expression of Evil in early mouse embryos has been described during development at 9.5 d.p.c., 12.5 d.p.c., and 14.5 d.p.c, by hybridization to sectioned embryos (Perkins et al., 1991b) . Because Evil mutant embryos die at 10.5 d.p.c., whole-mount in situ hybridization was performed on wild-type embryos at 8.5, 9.5, and 10.5 d.p.c, to identify the Evil expression pattern at these developmental stages in greater detail. At 8.5 d.p.c., high levels of expression were limited to the anterior section of the primary head folds (Fig.  8A) . By 9.5 d.p.c., limb bud and mesonephric duct expression was strong, with expression also detected in the forebrain, mesenchyme of the branchial arches, and tissues of the buccal cavity, particularly in the developing nasal pits. Branchial arch expression was highest in the anterior side of the mandibular arch and the posterior side of the maxillary arch, while expression in the second branchial arch was more uniform (Fig. 8B) . All of these regions express Evil at 10.5 d.p.c, although detection of expression in the mesonephros was weak (Fig. 8C,D) . In the trunk region, additional expression was observed lateral to the neural tube at the dorsal extreme of, and between, all somites. This pattern of expression resembles the position and structure of the dorsal root ganglia. In the rhombencephalic region of the embryo, Evil expression was observed in two axially oriented regions located lateral to the second branchial arch, near the otic vesicles. The more medial region is not associated with a well-defined structure (Kanfmann, 1992) , but may be an ectodermal (epibranchial) placode contributing to the placodal neurons of the cranial ganglia (D' AmicoMartel and Noden, 1983) . The more dorsally positioned of these regions is probably hindbrain rhombomere 4. Normal 9.5 and 10.5 d.p.c, embryos had ubiquitous low-level hybridization in whole-mount in situ hybridization experiments when compared to sense-strand controls which were devoid of any signal, suggesting that Evil may be expressed at low levels throughout the embryo. A similar inference was drawn from hybridization of an Evil probe to sectioned embryos (Perkins et al., 1991b) .
Homozygous mutant embryos were also examined by whole-mount in situ hybridization for expression of an alternatively processed Evil transcript: A324 (Bordereanx et al., 1990; Bartholomew and Clark, 1994) , which the targeted mutation of exon 6 detailed in this report would not necessarily eliminate. The A324 transcripts were detected in the forelimb buds of mutant embryos by 10.5 d.p.c. (Fig. BE) . The persistent expression of transcript A324 is diagrammed in Fig. 9A . To verify that the full-length transcript was disrupted, primers designed to distinguish between the 21324 alternate transcript and the full-length transcript (Bartholomew and Clark, 1994) were used on reversed transcribed, DNase-treated total RNA from wild-type, heterozygous, and homozygous mutant embryos at 10.5 d.p.c. (Fig. 9B) . These experiments showed that the predicted fragments were amplified in wild-type and beterozygous embryos, but that the mutant embryos lacked the full-length EviI transcript, while expressing A324.
Limb bud expression at 10.5 d.p.c, was the highest of any tissue, and was restricted to the mesenchyme. Because Evil encodes a transcription factor, whole-mount in situ hybridization analysis was performed to determine whether Evil might modulate the expression of three limb-pattern controlling genes: fibroblast growth factor-8 (Fgf8), fibroblast growth factor-4 (Fgf4), and sonic hedgehog (Shh). Fgf8 expression was detected in the AER of phenotypically normal and mutant embryos at 10.5 d.p.c. (Fig. 10A,B) . However, Fgf4 expression was never detected in the AER of mutant limb buds at 10.5 d.p.c, while expression of Shh was shown to be greatly reduced or absent in the zone of polarizing activity (ZPA) of mutant limb buds. (Fig. 10C-F ) Interestingly, Shh expression levels appeared normal in the neural tissues and notochord of Evil mutant embryos. No specific signal was detected using control, sense-strand, riboprobes for any of these genes. 
Discussion
W e have generated a targeted insertional mutation in the E v i l locus, resulting in the selective ablation o f the fulllength gene transcript. Heterozygous animals are indistinguishable from wild-type littermates. However, we have demonstrated that the full-length E v i l transcript is essential for normal embryonic development. The earliest defects detectable in mutant embryos are reduced trabeculation in the hearts, and disruption of cranial ganglia d6velopment at 9.5 d.p.c. In contrast, widespread, severe hypocellularity is evident, accompanied by massive hemorrhaging with multiple pleiotropic defects in the development of the heart, nervous system, somites, limb buds, and branchial arches at 10.5 d.p.c. The relationship between these phenotypic changes and E v i l expression was examined using wholemount in situ hybridization. With dependence on developmental age, high levels of E v i l expression were detected in 
g.
limb buds, the mesonephros, nasal pits, branchial arch mesenchyme, rhombomere 4, a putative ectodermal placode and dorsal root ganglia, with low levels of expression detected throughout midgestation embryos. Thus, many of the mutational effects are associated with tissues that express Evil during this specific developmental stage, although others, including heart and circulatory system failure, are not easily reconciled with high levels of Evil expression.
The establishment of functional hematopoietic and circulatory systems are critical during development. Mouse mutants that die at midgestation with circulatory system defects are generally deficient in hematopoiesis (Tsai et al., 1994; Warren et al., 1994; Robb et al., 1995; Shivdasani et al., 1995; Field et al., 1996) , vascular development of the yolk-sac or placenta or their respective connections to the embryo (Yang et al., 1993; Ang and Rossant, 1994; Weinstein et al., 1994; Fong et al., 1995) , or both (Dickson et al., 1995; Shalaby et al., 1995) . The placenta, and umbilical connections are grossly normal in Evil mutants, which also have a vascularized yolk sac containing hemoglobinized cells at 9.5 d.p.c. This suggests that hematopoiesis and vascularization are proceeding normally up to organogenesis. The Evil mutation most closely resembles the phenotype of mice mutated at the tissue factor (Tf) locus, which experience a sudden catastrophic failure in circulatory system integrity at midgestation (Bugge et al., 1996) .
In Evil mutants, heart failure, associated with or due to malformation of the trabeculae, and looping defects are the likely cause of death in mutant embryos. The failure of the vascular integrity and pericardial effusion are indicated by blood in the amnion, pericardium, and the body cavities of mutants. In histological sections of mutant animals no defects were localized to a specific vascular structure. We hypothesize that Evil mutants experience desultory circulatory system ruptures in defective vessel walls during new vascular development. A similar conclusion was drawn from analyses of the Tf-mutant mice (Bugge et al., 1996) . Many new embryonic blood vessels are formed as anastomosis of endothelial cells derived from mesodermal mesenchyme cells. In Evil mutants, it is likely that new blood vessels rupture as they attempt to form in a region of defective mesenchyme. However, the possibility of generalized tissue degeneration due to nutritional deficiencies has not been unequivocally eliminated.
Loss of circulation will eventually result in systemic anoxia and/or the accumulation of metabolic wastes. Published evidence argues against anoxia causing the mesenchymal malformation seen in Evil mutants. Lthler et al. (1984) showed that anoxia did not initiate with necrosis of the mesenchymal cell compartment. Also, in other reports of mutant mice that die at approximately midgestation, DNA methyltransferase (Li et al., 1992) , Tek (Dumont et al., 1994) , Mgat (Ioffe and Stanley, 1994; Metzler et al., 1994) , Rxrct (Sucov et al., 1994) , and Nfl (Brannan et al., 1994; Jacks et al., 1994) mutants have circulatory defects that result in bleeding. However, the phenotypes do not include ablation of the paraxial mesoderm observed in Evil mutants. In Tf mutants, a generalized necrosis is seen which is similar to the systemic hypocellularity and cell death seen in Evil mutants. Tf is regulated by a variety of cellular factors including AP-1 (Mackman, 1995) , and is known to affect the metastatic potential of a human melanoma cell line (Bromberg et al., 1995) . Thus, a functional relationship could exist between Tf and Evil.
In 10.5 d.p.c. Evil mutants, most of the nervous system structures are hypoplastic. No other reported mutation in mice precisely mimics these developmental malformations although Tf mutants (Bugge et al., 1996) also show an underdeveloped forebrain. The lack of spinal neurons in Evil mutants clearly suggests an effect on neural crest cell development, but the difficulty in specifying developmental stage in Evil mutants complicates this analysis. Nonetheless, Evil is expressed near the presumptive dorsal root ganglia of 10.5 d.p.c, embryos and these areas of expression may contribute to determination events of post-migratory neural crest cells, by signaling them to form neuronal structures. In the absence of these signals, neuron development is ablated. The result in the trunk region is the apparent absence of peripheral neurons.
The specific loss of neurons in the superior regions of cranial ganglia may be related to Evil expression in ectodermal placodes because in chickens, cranial ganglia neurons develop as mixed populations arising from both neural crest cells and from ectodermal placodes (D' Amico-Martel and Noden, 1983) . Fate-mapping placodal cells showed that epibranchial placodes contribute to the more distal (ventral) neurons of the petrosal, nodose, and trigeminal ganglia. Additionally, the marginal layer of the neural ectoderm consists of cells and structures which are normally involved in growth of neurons and neuroglial cells to form connections with dorsal root ganglia, motor, and sensory neurons. The absence of this layer in mutants suggests that development or migration of neurons is inhibited within the neural ectoderm, which would also result in the loss of spinal neuron structures. While developmental delay cannot be ruled out as a cause for lack of spinal and cranial nerve development, the marginal layer of 9.5 d.p.c. Evil mutants is poorly developed (data not shown) and the defects in superior cranial ganglia are detected before any observable developmental delay. An interesting related malformation in neural development occurs in Caenorhabditis elegans. A mutation in the C. elegans Egl-43 gene, which is a zinc finger gene related to the murine Evil gene (Garriga et al., 1993) causes specific neurons to either fall to form or migrate improperly during development.
High levels of Evil expression in the limb buds between 9.5 and 10.5 d.p.c, does not correlate with tissue ablation in Evil mutants. However, the expression of genes known to be involved in limb pattern formation, specifically Fgf4 and Shh, are altered in mutant limb buds, while Fgf8 is not. Whether Evil modulates the expression of these genes, or developmental delay causes the alteration in gene expression, remains to be definitively determined. In limb buds, there may also be a compensatory effect from the alternatively spliced (A324) transcript of Evil. The generation of Evil null-mutants may be necessary to resolve unambiguously whether A324 is translated into a functional protein.
The mechanism responsible for reduced cellularity and tissue failure in the paraxial mesenchyme has not been defined. However, the widespread hypocellularity that occurs between 9.5 and 10.5 d.p.c, suggests that Evil is required for general cell proliferation. This may be attributed to low levels of Evil expression seen throughout normal embryos in our whole-mount in situ hybridization experiments. This apparent role of Evil in modulating cell proliferation is consistent with the original isolation of Evil as an oncogene activated by retroviral insertion in murine leukemias. The hypocellularity of Evil mutant embryos correlates well with recent data showing that inhibition of transcription of an AML1/EVI1 chimeric gene causes decreased proliferation of leukemia cells . Additionally, Evil appears to have transforming properties when ectopically expressed . Taken together, these data indicate that the oncogenic properties of Evil seen in hematopoietic cells are probably the result of deregulated proliferation signals.
Notably, early development and proliferation are unaffected in Evil mutants, making the hypocellularity in Evil mutants similar to the pre-natal lethal phenotype of Cmyc (Davis et al., 1993) and Nmyc (Charron et al., 1992 ) mutant mice. In both instances, general hypocellularity begins at midgestation and is attributed to the ability of these genes to regulate cell proliferation. A similar hypocellular phenotype was also described in mice mutated at the Mgatl locus (Ioffe and Stanley, 1994; Metzler et al., 1994) . It will be of interest to determine if there is a functional relationship between the products of these loci and Evil. electroporated into 1 x 107 ES-D3 embryonic stem cells, and Evil targeted cells were identified as described previously (Mucenski et al., 1991) . PCR analysis to identify targeted clones (Mullis and Faloona, 1987) .was performed using primers KO2 (5'-CT'VrAATATGCGAAGTGGACC-3') and KO4 (5'-AAAACACACACAGAAGC-3'). Amplified DNAs were separated by electrophoresis, blotted onto nylon membranes, and hybridized as previously described to a 400 base pair (bp) unique sequence SstI-PstI internal probe designated SP (Mucenski et al., 1991) . Southern blot analysis of individual ES cell clones from positive pools was used to identify targeted clones. Evil targeted ES cells were injected into blastocysts and the resulting chimeric animals were then mated to CF-1 female mice.
PCR analysis
Genomic DNA from cell lines was prepared according to standard methods (Ausubel et al., 1994) . Genomic DNA from mouse tail biopsies and yolk sacs was prepared by placing the tissue in lysis buffer (10 mM Tris, pH 7.5; 100 mM NaC1, 10 mM EDTA, 0.5% SDS, 0.1 mg/ml proteinase K), incubation overnight at 45°C, purification by phenol/ chloroform extraction, and ethanol precipitation. Evil targeted alleles were identified using PCR analysis and primers derived from the 5'-and 3'-regions of exon 6. The primers used were 5'-ACACAGGAGGTTTTGTGAGGG-3' and 5'-GCAGGAATGCCTATTGGTGC-3'. Polymerase reactions were carded out according to the enzyme manufacturer's recommendations (Perkin Elmer) with MgCI2 concentration adjusted to 3 mM.
Histological analysis
For sectioning, embryos were fixed in 4% paraformaldehyde, embedded in methacrylate, cut into 1/~m sections, and stained with hematoxylin and eosin (Humason, 1972) .
Experimental procedures
Whole-mount in situ hybridization
Evil targeting construct
The targeting vector, pCBiEx6neol, was derived from a 10.5 kilobase (kb) EcoRI fragment of the BALB/c-derived clone ~CB1 (Bartholomew and Ihle, 1991) . A 5.5 kb EcoRISstI fragment containing exon 6 was inserted into the corresponding restriction enzyme sites of the polylinker of the Bluescript II KS(+) plasmid (Stratagene) to create pCBEx6. The 1.2 kb XhoI to Sail neo r cassette from pMClneolpoly-A + (Stratagene) was blunt-ended and inserted into SmaIdigested pCBEx6 in the same transcriptional orientation as Evil, creating the targeting vector pCB 1Ex6neol.
Production of Evil mutant mice
Twenty-five micrograms of linearized pCB 1Ex6neo 1 was All DNA preparations and manipulations were carried out using standard methodologies (Sambrook et al., 1989; Ausubel et al., 1994) . To detect all known transcripts of the Evil gene in whole-mount in situ hybridization experiments, a 1.2 kb SphI fragment of the Evil cDNA 58.2 (Morishita et al., 1988) was inserted in both orientations into the SphI site of PUC 19, then excised using external EcoRI/ HindlII restriction enzyme sites and inserted into Bluescript II SK + (Stratagene) generating template plasmids designated BSES1.2(+) and BSES1.2(-). Sense (+) or antisense (-) Evil riboprobes were transcribed from these templates with T3-RNA polymerase after ClaI linearization of the appropriate template in the presence of digoxigenin (DIG)-UTP using a commercially available kit (Boehringer Mannheim). All other riboprobes were prepared similarly. The Fgf8 template contained 800 bp including the 3'-untranslated region and the entire coding region of a spliced variant of Fgf8 (Crossley and Martin, 1995) (Hebert et al., 1991) and contained a full-length cDNA of the mouse Fgf4 gene.
Embryos were harvested from crosses of Evil heterozygous mice at 8.5, 9.5, and 10.5 d.p.c, in RNase-free phosphate buffered saline (PBS) containing 10% fetal bovine serum (FBS), and washed twice in RNase-free PBS + 10% FBS while still within the yolk sac. Subsequently, the yolk sac and amnion were removed and embryos washed in RNase-free PBS, then fixed at 4°C in freshly prepared RNase-free 4% paraformaldehyde in PBS. Embryos were dehydrated through a series of increasing concentrations of methanol in TBS, and if necessary, stored in 100% methanol at -20°C and rehydrated before use by reversing the methanol washes. With dependence on their hypocellularity, homozygous mutant embryos shrank disproportionately during dehydration, and remained smaller during subsequent analyses. For whole-mount in situ hybridization, a modification of the technique of D.G. Wilkinson was used (Wilkinson, 1992) . Briefly, embryos were bleached with 4:1 methanol/30% hydrogen peroxide, washed with PBT (PBS containing 0.1% Tween-20), treated with 15/~g/ml Proteinase K for 5 min, washed with PBT, re-fixed in 0.2% glutaraldehyde/4% paraformaldehyde, washed, and hybridized overnight at 70°C to 1/~g/ml of strand-specific DIG-labeled sense or antisense riboprobe. Unbound probe was washed away, and embryos were treated with RNase A at 100 tzg/ ml. After blocking non-specific protein binding sites with 10% FBS and a commercial blocking reagent (Boehringer Mannheim), embryos were incubated overnight at 4°C with pre-absorbed anti-DIG alkaline phosphatase-conjugated FAb antibody (Boehringer Mannheim). Unbound antibody was washed away and a color reaction performed using the BM-purple precipitating reagent (Boehringer Mannheim).
Reverse transcriptase-mediated polymerase chain reaction (RT-PCR )
Total RNA was isolated using a GeneAmp kit (Perkin Elmer). RT-PCR analysis (Kawasaki, 1990) was performed using the primers HMEI and HME5 as previously described (Bartholomew and Clark, 1994) .
Whole-mount immunohistochemical detection of neurofilaments
Antibody to the 155 kDa neurofilament protein (2H3, fresh hybridoma supernate, Developmental Studies Hybridoma Bank) was used to detect neuronal development in whole embryos at 9.5 and 10.5 d.p.c. Embryos were extracted as described previously, then washed in PBS, three times for 1 h each at 4°C, followed by an overnight treatment in blocking buffer (PBS + 0.1% H202, 1.0% Triton X-100, 5.0% fetal bovine serum) at 4°C. Subsequently, the embryos were washed three times in solution 1 (PBS + 1% Triton X-100, 5.0% fetal bovine serum), 1 h each at 4°C. This was followed by treatment with a 1:1 mixture of DMEM (Gibco BRL):hybridoma supernate for 48 h at 4°C. The embryos were then washed three times in solution 2 (PBS + 1.0% goat serum, 1.0% Triton X-100) 1 h each at 4°C, followed by the addition of the secondary antibody (goat anti-mouse IgGl-horseradish peroxidase conjugate, Boehringer Mannheim) diluted 1:100 in solution 2, and incubated overnight at 4°C. Excess antibody was removed by washing the embryos three times in solution 2 for 1 h at 4°C. The embryos were then incubated in the dark for 3 h at 4°C in TBS + 0.05% diaminobenzidine, 0.5% NiC12-7H20. Activation of the color reaction was initiated by adding H2Oz to 0.03% and placing the embryos at room temperature until the color had developed sufficiently. The color reaction was stopped by repeated washing in PBS. Prior to photography, the transparency of the embryos was increased by sequential incubation of the embryos, overnight at 4°C, in 25%, 50%, 75%, and 100% glycerol in TBS buffer.
